Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling

The antitumor potency of the mTOR inhibitor rapamycin (sirolimus) is the subject of intense investigations. Primary effusion lymphoma (PEL) appears as an AIDS-defining lymphoma and like Kaposi sarcoma has been linked to Kaposi sarcoma–associated herpesvirus (KSHV). We find that (1) rapamycin is effi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sin, Sang-Hoon, Roy, Debasmita, Wang, Ling, Staudt, Michelle R., Fakhari, Farnaz D., Patel, Dhavalkumar D., Henry, David, Harrington, William J., Damania, Blossom A., Dittmer, Dirk P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2007
Assuntos:
Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1801055/
https://ncbi.nlm.nih.gov/pubmed/17082322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-06-028092
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados